Clinical Trial

Evaluation of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology

Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This study aims to reduce pain during interventional radiology (IR) procedures, making the experience better for patients. Typically, doctors use medications like fentanyl and midazolam for sedation. This research will focus on patients undergoing biopsies and drainage procedures, often associated with significant discomfort. Patients will be randomly assigned to receive either fentanyl/midazolam or ketamine/midazolam combinations for sedation. A coordinator will collect information on pain levels and satisfaction, as well as monitor any extra medications needed and side effects. The investigators hope to find that ketamine helps decrease pain and improves satisfaction compared to fentanyl, without increasing complications.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-24.
Status change: Recruiting → Active, Not Recruiting 2026-02-19
Trial Details
NCT Number NCT07040163
Lead Sponsor CAMC Health System
Collaborators: Sarah & Pauline Maier Foundation, Inc., Radiological Society of North America, Society of Interventional Radiology Foundation
Conditions Sedation, Interventional Radiology, Biopsy, Drainage Procedure
Enrollment 276 participants
Start Date 2025-03-07
Primary Completion 2026-02-13 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-23